FGFR1 and bladder transitional cell carcinoma: In summary, this study is the first to elucidate the critical regulatory role of FGFR1 in the initiation and progression of BLCA through the cGMP-PKG signaling pathway, thereby identifying a novel potential therapeutic target for BLCA treatment.